Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1777

PDF: 519

HTML: 75
Treatment satisfaction among patients with psoriasis in Saudi Arabia

Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi

15-04-2024

https://doi.org/10.4081/dr.2024.9967

1039

PDF: 553

HTML: 29
Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1306

PDF: 548

HTML: 34
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

13-09-2023

https://doi.org/10.4081/dr.2023.9839

2686

PDF: 982

HTML: 31
Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Mishari T. Alrubaiaan, Abdullah D. Alhobabi, Raghad M. Alharthi, Saad A. Alsulaiman, Abdullah N. Altasan, Ibrahim M. Momen, Mohammad Almohideb

02-01-2025

https://doi.org/10.4081/dr.2025.10083

687

PDF: 361

HTML: 27
Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Valeria Corazza, Francesco Cusano, Ornella De Pità, Luigi Rossi, G. Giovanni Virno

28-12-2021

https://doi.org/10.4081/dr.2022.9454

4113

PDF: 665

APPENDIX: 172

HTML: 15
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

746

PDF: 366

HTML: 27
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1531

PDF: 450

HTML: 27
A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project

Francesco Cusano, Francesca Sampogna, Alexandra Maria Giovanna Brunasso Vernetti, Stefano Stisi, Gilda Sandri, Giovanna Malara, Luigi Naldi, Michele Pellegrino, Giovanni Luigi Tripepi, Umberto di Luzio Paparatti, Concetto Paolo Agnusdei, Claudio Bonifati, Antonella Celano, Valeria Corazza, Federica D'Agostino, Rocco De Pasquale, Emilio Filippucci, Rosario Foti, Giovanna Galdo, Fabiana Gai, Giulia Ganzetti, Dario Graceffa, Mara Maccarone, Annamaria Mazzotta, Gennaro Melchionda, Francesca Molinaro, Franco Paoletti, Silvia Tonolo, Adriano Vercellone, Rosetta Vitetta, Cesare Massone, Gian Domenico Sebastiani

26-09-2022

https://doi.org/10.4081/dr.2022.9541

1254

PDF: 704

HTML: 36
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1057

PDF: 546

HTML: 19
S-MAPA: bridging the gap in psoriasis severity assessment

Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

28-05-2025

https://doi.org/10.4081/dr.2025.10231

621

PDF: 282

HTML: 15
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1739

PDF: 669

HTML: 94
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

989

PDF: 521

SUPPLEMENTARY MATERIAL: 153

HTML: 16
The role of gut microbiome in inflammatory skin disorders: A systematic review

Suci Widhiati, Dewajani Purnomosari, Tri Wibawa, Hardyanto Soebono

28-12-2021

https://doi.org/10.4081/dr.2022.9188

5846

PDF: 2693

HTML: 32
Progress in psoriasis therapy via novel drug delivery systems

Nitha Vincent, Ramya Devi D, Vedha Hari BN

08-09-2014

https://doi.org/10.4081/dr.2014.5451

3567

PDF: 2182

HTML: 696
Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques

11-09-2023

https://doi.org/10.4081/dr.2023.9824

884

PDF: 543

HTML: 32
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1139

PDF: 620

HTML: 21
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

14-07-2022

https://doi.org/10.4081/dr.2022.9516

1640

PDF: 720

HTML: 21
Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan

21-11-2022

https://doi.org/10.4081/dr.2022.9492

1686

PDF: 679

HTML: 85
Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

13-03-2025

https://doi.org/10.4081/dr.2025.10021

441

PDF: 304

HTML: 7
Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

30-05-2025

https://doi.org/10.4081/dr.2025.10414

662

PDF: 381

HTML: 16
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1172

PDF: 659

HTML: 27
Erythrodermic psoriasis treated with apremilast

John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul

19-09-2016

https://doi.org/10.4081/dr.2016.6599

2122

PDF: 964

HTML: 600
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

965

PDF: 564

HTML: 25
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2625

PDF: 632

HTML: 6

1 - 25 of 125 items 1 2 3 4 5 > >>

Search

Search Results

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Treatment satisfaction among patients with psoriasis in Saudi Arabia

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

Prevalence and association of renal disorders in Saudi adult patients with psoriasis and psoriatic arthritis: a tertiary-center retrospective cross-sectional study

Methotrexate in the therapeutic pathway of patients with psoriasis. Analysis of clinical practice data and comparison with guidelines

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

S-MAPA: bridging the gap in psoriasis severity assessment

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

The role of gut microbiome in inflammatory skin disorders: A systematic review

Progress in psoriasis therapy via novel drug delivery systems

Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

Erythrodermic psoriasis improved by tildrakizumab

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Erythrodermic psoriasis treated with apremilast

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

authors

reviewers

Categories

indexing

dermatopathology